Microchip Technology
MCHPNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $60.33 Prior regular-session close from the quote source.
- $61.13–$63.78 Regular-session low and high so far today.
- 12.6M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Feb 4 projected Projected for 2027-02-04 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $48.52–$105.91 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own MCHP if design-win momentum and margin mix hold.
MCHP price history
Loading recent earnings…
Investment thesis
What must happen next
Multi-year OEM design wins and high switching costs keep Microchip’s revenue resilient and convert product cycles into recurring sales rather than one-off chip purchases.HoldingMateriality: High
FY26 revenue rose to 4,713,100,000 USD from 4,401,600,000 USD in FY25 (evidence of a recovery step). If design wins hold, revenue stays stable or grows and gives predictable cash to fund buybacks/debt reduction; if customers migrate designs away, revenue will decline before margins recover.
Watch: Large OEMs consolidate designs on competitors (e.g., NXP, ST, TI or integrated SoC providers) and stop selecting Microchip parts.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY26 revenue rose to 4,713,100,000 USD from 4,401,600,000 USD in FY25 (evidence of a recovery step).
Open source ↗A product mix weighted toward differentiated analog and mixed-signal parts supports gross-profit resilience and protects pricing versus commodity MCU suppliers.HoldingMateriality: High
Gross profit increased to 2,721,100,000 USD in FY26 from 2,467,900,000 USD in FY25 (implying improved product mix or pricing). If mix toward higher-value analog/mixed-signal continues, gross profit and gross margins should stay stable even if unit volumes are lumpy; if mix flips to commoditized products, pricing and gross profit will erode.
Watch: Aggressive pricing or bundling by large analog/MCU competitors (TI, NXP, Renesas) erodes premium pricing.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Gross profit increased to 2,721,100,000 USD in FY26 from 2,467,900,000 USD in FY25 (implying improved product mix or pricing).
Open source ↗Modest top-line growth can produce outsized operating-income expansion because Microchip can leverage fixed R&D/SG&A and realize cost discipline after trough volumes.StrengtheningMateriality: Medium
Operating income rose to 490,100,000 USD in FY26 from 296,300,000 USD in FY25 (operating leverage in action). If operating leverage continues, shareholders get margin expansion and rising free cash flow without large incremental capex; if costs re-accelerate or R&D/M&A spend rises, margin recovery will stall.
Watch: Management ramps R&D or makes large tuck-in acquisitions that expand operating expense and dilute leverage.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating income rose to 490,100,000 USD in FY26 from 296,300,000 USD in FY25 (operating leverage in action).
Open source ↗Net income and free-cash generation are volatile and remain sensitive to cycle, product concentration and one-time items, so shareholder returns hinge on disciplined capital allocation (debt reduction, buybacks) rather than reliable EPS compounding.StrengtheningMateriality: Medium
Net income swung from 1,906,900,000 USD (FY24) to -500,000 USD (FY25) then to 230,000,000 USD (FY26), demonstrating earnings volatility. Volatility means shareholders rely on management’s allocation choices to realize value; poor allocation (bad M&A, high dilution) will destroy value even if revenues recover.
Watch: Large, value-destroying acquisitions that add debt and impairments (raising interest/expense load).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Net income swung from 1,906,900,000 USD (FY24) to -500,000 USD (FY25) then to 230,000,000 USD (FY26), demonstrating earnings volatility.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Multi-year OEM design wins and high switching costs keep Microchip’s revenue resilient and convert product cycles into recurring sales rather than one-off chip purchases. If design wins hold, revenue stays stable or grows and gives predictable cash to fund buybacks/debt reduction; if customers migrate designs away, revenue will decline before margins recover.
A product mix weighted toward differentiated analog and mixed-signal parts supports gross-profit resilience and protects pricing versus commodity MCU suppliers. If mix toward higher-value analog/mixed-signal continues, gross profit and gross margins should stay stable even if unit volumes are lumpy; if mix flips to commoditized products, pricing and gross profit will erode.
Modest top-line growth can produce outsized operating-income expansion because Microchip can leverage fixed R&D/SG&A and realize cost discipline after trough volumes. If operating leverage continues, shareholders get margin expansion and rising free cash flow without large incremental capex; if costs re-accelerate or R&D/M&A spend rises, margin recovery will stall.
Net income and free-cash generation are volatile and remain sensitive to cycle, product concentration and one-time items, so shareholder returns hinge on disciplined capital allocation (debt reduction, buybacks) rather than reliable EPS compounding. Volatility means shareholders rely on management’s allocation choices to realize value; poor allocation (bad M&A, high dilution) will destroy value even if revenues recover.
All standing thesis claims
Original report summary
design-win momentum and margin mix hold.
Bull case and bear case
Bull case and bear case for Microchip Technology
Where the evidence on Microchip Technology stands: Holding on the latest evidence (Nov 9, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.
Bull case: what the evidence supports
Multi-year OEM design wins and high switching costs keep Microchip’s revenue resilient and convert product cycles into recurring sales rather than one-off chip purchases.
A product mix weighted toward differentiated analog and mixed-signal parts supports gross-profit resilience and protects pricing versus commodity MCU suppliers.
Modest top-line growth can produce outsized operating-income expansion because Microchip can leverage fixed R&D/SG&A and realize cost discipline after trough volumes.
Net income and free-cash generation are volatile and remain sensitive to cycle, product concentration and one-time items, so shareholder returns hinge on disciplined capital allocation (debt reduction, buybacks) rather than reliable EPS compounding.
Bear case: what would count against it
Large OEMs consolidate designs on competitors (e.g., NXP, ST, TI or integrated SoC providers) and stop selecting Microchip parts.
Aggressive pricing or bundling by large analog/MCU competitors (TI, NXP, Renesas) erodes premium pricing.
Management ramps R&D or makes large tuck-in acquisitions that expand operating expense and dilute leverage.
Thesis-Break Engine
Thesis-break watch · Microchip Technology
Loading the break-condition record for Microchip Technology.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Microchip Technology filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Microchip Technology filed an SEC 8-K on 2026-08-19: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Microchip Technology filed an SEC 8-K on 2026-08-06: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Large OEMs consolidate designs on competitors (e.g., NXP, ST, TI or integrated SoC providers) and stop selecting Microchip parts.
- Aggressive pricing or bundling by large analog/MCU competitors (TI, NXP, Renesas) erodes premium pricing.
- Management ramps R&D or makes large tuck-in acquisitions that expand operating expense and dilute leverage.
- Large, value-destroying acquisitions that add debt and impairments (raising interest/expense load).
MCHP news
Loading headlines…
Financial statements
MCHP income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
MCHP: quick answers
- When does Microchip Technology (MCHP) report earnings next?
- Microchip Technology's next results are projected for February 4, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
- What is MCHP's short interest?
- As of October 30, 2026, 36.6M MCHP shares were sold short, 6.72% of its shares outstanding, up 17.0% from the count before. At the stock's average daily volume that is 3.2 days to cover. FINRA publishes the count twice a month. MCHP short interest history
- Have members of Congress traded MCHP?
- Reports made public in the last 90 days disclose 3 trades in MCHP by 2 filers: 1 purchase and 2 sales. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed MCHP trade
- Which well-known investors own MCHP?
- 4 of the 37 well-known funds tracked here reported MCHP shares in their latest 13F filings. By share of the fund's portfolio: Glenview Capital Management, 0.4%; Soros Fund Management (George Soros), 0.3%; Bridgewater Associates (Ray Dalio), 0.1%. Fund portfolios
MCHP in well-known investors’ portfolios
4 of 37 funds reported MCHP shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Glenview Capital Management | 0.44% | $24.2M | New | Q2 2026 |
| George SorosSoros Fund Management | 0.26% | $20.8M | New | Q2 2026 |
| Ray DalioBridgewater Associates | 0.10% | $25.2M | +853.3% | Q2 2026 |
| Maverick Capital | 0.01% | $657K | New | Q2 2026 |
